185 related articles for article (PubMed ID: 35277197)
1. Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era.
Shi T; Xie M; Chen L; Yuan W; Wang Y; Huang X; Xie W; Meng H; Lou Y; Yu W; Tong H; Ye X; Huang J; Jin J; Zhu H
Exp Hematol Oncol; 2022 Mar; 11(1):13. PubMed ID: 35277197
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of Clinical Outcomes between P190 and P210 Trans-cripts in Adult Ph Chromosome Positive Acute Lymphoblastic Leukemia in the New Era of TKI].
Qiu LL; Lu YJ; Jing Y; Yu L; Liu DH; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):369-74. PubMed ID: 27150994
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant.
Samra B; Kantarjian HM; Sasaki K; Alotaibi AS; Konopleva M; O'Brien S; Ferrajoli A; Garris R; Nunez CA; Kadia TM; Short NJ; Jabbour E
Acta Haematol; 2021; 144(3):285-292. PubMed ID: 33238261
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.
Morita K; Kantarjian HM; Sasaki K; Issa GC; Jain N; Konopleva M; Short NJ; Takahashi K; DiNardo CD; Kadia TM; Garcia-Manero G; Daver N; Montalban Bravo G; Cortes JE; Ravandi F; Jabbour E
Cancer; 2021 Aug; 127(15):2641-2647. PubMed ID: 33823073
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era.
Shi T; Wang H; Xie M; Li X; Zhu L; Ye X
Clinics (Sao Paulo); 2020; 75():e2011. PubMed ID: 33206758
[TBL] [Abstract][Full Text] [Related]
6. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922
[TBL] [Abstract][Full Text] [Related]
7. Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage.
Järås M; Johnels P; Agerstam H; Lassen C; Rissler M; Edén P; Cammenga J; Olofsson T; Bjerrum OW; Richter J; Fan X; Fioretos T
Exp Hematol; 2009 Mar; 37(3):367-75. PubMed ID: 19135771
[TBL] [Abstract][Full Text] [Related]
8. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
[TBL] [Abstract][Full Text] [Related]
9. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia.
Kantarjian HM; Talpaz M; Dhingra K; Estey E; Keating MJ; Ku S; Trujillo J; Huh Y; Stass S; Kurzrock R
Blood; 1991 Nov; 78(9):2411-8. PubMed ID: 1932753
[TBL] [Abstract][Full Text] [Related]
10. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
Serrano J; Roman J; Sanchez J; Jimenez A; Castillejo JA; Herrera C; Gonzalez MG; Reina L; Rodriguez MC; Alvarez MA; Maldonado J; Torres A
Blood; 2000 Apr; 95(8):2659-65. PubMed ID: 10753848
[TBL] [Abstract][Full Text] [Related]
12. Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage-Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities.
Komorowski L; Fidyt K; Patkowska E; Firczuk M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806528
[TBL] [Abstract][Full Text] [Related]
13. Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults.
El Fakih R; Jabbour E; Ravandi F; Hassanein M; Anjum F; Ahmed S; Kantarjian H
Am J Hematol; 2018 Feb; 93(2):286-295. PubMed ID: 28971501
[TBL] [Abstract][Full Text] [Related]
14. The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation.
Tachibana T; Najima Y; Akahoshi Y; Hirabayashi S; Harada K; Doki N; Uchida N; Fukuda T; Sawa M; Ogata M; Takada S; Tanaka M; Matsuhashi Y; Tanaka J; Onizuka M; Ichinohe T; Atsuta Y; Kako S;
Ann Hematol; 2020 Oct; 99(10):2393-2404. PubMed ID: 32803312
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of armored RNA-based standards for quantification of BCR-ABL1
Fu Y; Zhang R; Wu Q; Zhang J; Bao L; Li J
J Clin Lab Anal; 2018 Nov; 32(9):e22612. PubMed ID: 29959790
[TBL] [Abstract][Full Text] [Related]
16. Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome.
Reboursiere E; Chantepie S; Gac AC; Reman O
Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):28-33. PubMed ID: 25300567
[TBL] [Abstract][Full Text] [Related]
17. Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190
Qin R; Wang T; He W; Wei W; Liu S; Gao M; Huang Z
Cell Commun Signal; 2023 Jan; 21(1):27. PubMed ID: 36721266
[TBL] [Abstract][Full Text] [Related]
18. [Clinical Analysis of Dasatinib and Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia].
Li Y; Wang BJ; Liu W; Liang ZY; Yin Y; Dong YJ; Wang Q; Sun YH; Xu WL; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):18-23. PubMed ID: 32027247
[TBL] [Abstract][Full Text] [Related]
19. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
Winter SS; Greene JM; McConnell TS; Willman CL
Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
[TBL] [Abstract][Full Text] [Related]
20. T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
Ting S; Mixue X; Lixia Z; Xueying L; Wanzhuo X; Xiujin Y
Ann Hematol; 2020 Apr; 99(4):829-834. PubMed ID: 32107574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
